Therapeutic Asset Ratings
1,553 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Bcma Car T Cells
B-Cell Non-Hodgkin Lymphoma
Shanghai Cell Therapy Group Co.,Ltd
Early P1
C
(39)
Bcma Car T Cells
POEMS Syndrome
Zhejiang University
Early P1
C
(39)
Bcma Car T Cells
Vasculitis
Zhejiang University
Early P1
C
(39)
Bcma-Gprc5D Car-T
Multiple Myeloma Refractory
Guangzhou Bio-gene Technology Co., Ltd
Early P1
C
(39)
Bcma Targeted Car T-Cells
Autoimmune Encephalitis
Tongji Hospital
Early P1
C
(39)
Bcma Targeted Car T-Cells
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Tongji Hospital
Early P1
C
(39)
Bcma Targeted Car T-Cells
Myasthenia Gravis
Tongji Hospital
Early P1
C
(39)
Bcma Targeted Car T-Cells
Non-Hodgkin Lymphoma
Zhejiang University
Early P1
C
(39)
Bcma Targeted Car T-Cells
Multiple Sclerosis
Tongji Hospital
Early P1
C
(39)
Beetroot Juice - Active
Metabolic Syndrome
Penn State University
Early P1
C
(39)
betacarotene
Opiate Dependence
Yale University
Early P1
C
(39)
BICARBONATE ION
Prostate Carcinoma
Robert Flavell, MD, PhD
Early P1
C
(39)
BIOTINYLATED HUMAN RED BLOOD CELL
Hemoglobinopathy
National Heart, Lung, and Blood Institute (NHLBI)
Early P1
C
(39)
BIOTINYLATED HUMAN RED BLOOD CELL
Thalassemia
National Heart, Lung, and Blood Institute (NHLBI)
Early P1
C
(39)
Bisoprolol Fumarate
CAR T-Cell Therapy
University of Arizona
Early P1
C
(39)
Bisoprolol Fumarate
Donor Lymphocyte Infusion
University of Arizona
Early P1
C
(39)
Bisoprolol Fumarate
Disease Related To Hematopoietic Stem Cell Transplant
University of Arizona
Early P1
C
(39)
bmd003
Gene Therapy
Peking Union Medical College Hospital
Early P1
C
(39)
bmd006
Lung Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early P1
C
(39)
BMS-986504
Glioblastoma
Nader Sanai
Early P1
C
(39)
Botensilimab
Non-MSI-H or pMMR Colorectal Cancer With Liver Metastasis
Massachusetts General Hospital
Early P1
C
(39)
Brentuximab Vedotin
Aggressive NK-Cell Leukemia
New York Medical College
Early P1
C
(39)
Brentuximab Vedotin
T-Cell And NK-Cell Neoplasm
New York Medical College
Early P1
C
(39)
B. Subtilis
Irritable Bowel Syndrome
Jinling Hospital, China
Early P1
C
(39)
B. Subtilis
Purine Metabolism Disease
Jinling Hospital, China
Early P1
C
(39)
Showing 276 to 300 of 1,553 assets
Previous
Page 12 of 63
Next
